Medical Implant Market
P
2024
The global medical implant market size was valued at $112.8 billion in 2023, and is projected to reach $225.7 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033. Rise in aging population and increase in prevalence of chronic diseases are some of the major driving factors for the medical implants market. Aged people are more susceptible to chronic diseases such as cardiovascular diseases, orthopedic disorders, endovascular diseases, and dental disorders, thus being the major users of medical implants. For instance, with the increasing aging population, the demand for tooth loss is expected to grow. According to the American Academy Of Implant Dentistry (AAID), about 3 million people in the U.S. currently have dental implants, and this number is expected to grow by 500,000 annually.
Medical implant is a medical device or tissue, which is surgically transplanted inside the body. These implants are used to replace or support any damaged body organs to normalize body functioning. They can be either implanted permanently or temporarily and can be removed when they are no longer required. Some of the implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials.
The medical implants market is experiencing significant growth, propelled by technological advancements, an aging population, and an increasing prevalence of chronic diseases. Innovations in materials science and biotechnology are leading to the development of more durable, biocompatible, and integrative implants. Technologies such as 3D printing are revolutionizing custom implant manufacturing, allowing for personalized solutions tailored to individual patient anatomies. Major segments such as orthopedic and cardiovascular implants are seeing substantial demand. Orthopedic implants benefit from the rising incidence of osteoarthritis, osteoporosis, and sports injuries, while cardiovascular implants such as pacemakers, stents, and defibrillators are in high demand due to the growing prevalence of cardiovascular diseases and advancements in minimally invasive procedures.
The market is further maintained by the increasing elderly population, who are more susceptible to conditions requiring implants. Neurostimulators and cochlear implants are also gaining traction due to their effectiveness in treating chronic pain, epilepsy, Parkinson’s disease, and severe hearing loss. Favorable regulatory frameworks and reimbursement policies in developed regions enhance market growth by ensuring the safety and efficacy of implants, boosting patient confidence and adoption rates. Additionally, emerging markets in Asia-Pacific and Latin America are experiencing rapid growth due to improving healthcare infrastructure and rising healthcare expenditure. The preference for minimally invasive surgeries, which offer reduced recovery times and lower risks, is also driving demand for associated implants, ensuring the market's sustained expansion.
Statement from Industry Leader
In April 2024, Amir Aghdaei, CEO of Envista Holdings Corporation, pointed out the strong growth trajectory in the dental implant sector, fueled by advancements in digital dentistry and patient-specific solutions. Aghdaei mentioned the company's innovative implant systems and digital workflows that enhance precision and efficiency in dental procedures. He also noted the rising demand for aesthetic and functional dental restorations, which is driving market expansion and technological developments |
The medical implant market share is segmented into product, and biomaterial type. Depending on product type, the medical implant industry is categorized into orthopedic implants, cardiovascular implants, spinal implant, neurostimulators, ophthalmic implants, dental implants, facial implants, and breast implants. Orthopedic implants are further divided into Reconstructive Joint Replacements, Orthobiologics and Trauma & Craniomaxillofacial. Cardiovascular Implants are further classified into Pacing Devices, Stents, and Structural Cardiac Implants. Spinal Implants are divided into Spinal fusion implants, Spinal bone stimulators, Vertebral Compression Fracture (VCF) Devices, and Motion Preservation Devices/Non-Fusion Devices. Neurostimulators are segregated into Deep Brain Stimulation (DBS) , Sacral Nerve Stimulation (SNS) , Vagus Nerve Stimulation (VNS) , Spinal Cord Stimulation (SCS) , and Other neurostimulators. Ophthalmic Implants are bifurcated into Intraocular Lens and Glaucoma Implants. Dental Implants are bifurcated into Plate Form Dental Implants and Root Form Dental Implants. Based on biomaterial type, it is segregated into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and natural biomaterials. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America occupies the largest market for medical implants, followed by Europe. This is due to advancements in medical technologies, growing elderly population, increasing prevalence of chronic diseases, rise in health care expenditure, and improved health care infrastructure in the region. The medical implants market in Asia Pacific is also expected to grow at a high CAGR during the medical implant market forecast years. This is attributed to the increasing aging population, growing awareness about therapeutic applications of medical implants, increasing prevalence of chronic diseases, rising disposable income, and developing health care infrastructure in the region. In addition, rising demographics and economies in developing countries, such as India and China, are expected to lead to the growth in the medical implants market in Asia.
The major companies profiled in the report include BIOTRONIK, Boston Scientific Corporation, Conmed Corporation, Globus Medical, Inc., Institut Straumann AG, Integra Lifesciences Holdings Corporation, Johnson & Johnson, LivaNova Plc, Medtronic Plc and Nuvasive, Inc.
Aspect | Details |
---|---|
![]() Market Size By 2033 | USD 225.7 Billion |
![]() Growth Rate | CAGR of 7.2% |
![]() Forecast period | 2024 - 2033 |
![]() Report Pages | 300 |
By Product |
|
By Biomaterial Type |
|
By Region |
|
Key Market Players | Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Institut Straumann AG, CONMED Corporation, Medtronic plc, Johnson & Johnson, Globus Medical, Inc., LivaNova PLC, Biotronik, NuVasive, Inc. |
Few trends in medical implants market include trends include personalized implants for enhanced patient outcomes and the integration of sensors for real-time health monitoring.
Orthopedic implants are the leading product segment in Medical Implant Market in 2023
North America is the leading regional market in Medical Implant Market in 2023
The medical implant market was valued at $112.81 billion in 2023 and is estimated to reach $225.74 billion by 2033, exhibiting a CAGR of 7.2% from 2024 to 2033.
BIOTRONIK, Boston Scientific Corporation, and Conmed Corporation are few of the top companies to hold major share in the medical implant market